In the global context, the growing availability of the Antiretroviral Therapy (TAR) firstline Children with HIVtogether with an improved monitoring of the viral load, has increased the need for second -line therapies after the Virological failure. In Africa, where most of these children reside, the optimal second -line TAR options are not yet well defined. […]
Source link